Anyone else frustrated with the SP with all the positive news we have received lately?, page-199

"II this doesn't indicate that Merck or a controlling interest in them don't have a certain game plan when they are interested in taking over or collaborating with companies then I don't know what does ."

That proves nothing of that sort because the price movement in question was caused by expectations of payments to be received from Merck regardless of the price of Absci's shares.

"Under the collaboration, Absci will deploy its Bionic Protein™ non-standard amino acid technology to produce enzymes tailored to Merck’s biomanufacturing applications and receive an upfront and certain other milestone payments. In addition, Merck has the option to nominate up to three targets and enter into a drug discovery collaboration agreement, and Absci would then be eligible to receive up to $610 million in upfront fees and milestone payments for all three targets, as well as research funding and tiered royalties on sales."